First Stem Cell Drug Fails 2 Late-Stage Clinical Trials
The failure of Prochymal, from Osiris Therapeutics, is a setback for the use of adult stem cells to fight organ rejection.br clear=both style=clear: both;/
br clear=both style=clear: both;/
a href=http://ads.pheedo.com/click.phdo?s=b6a9c8fdd23c8a6658dd10ba57516d61p=1img alt= style=border: 0; border=0 src=http://ads.pheedo.com/img.phdo?s=b6a9c8fdd23c8a6658dd10ba57516d61p=1//a
img alt= height=0 width=0 border=0 style=display:none src=http://a.rfihub.com/eus.gif?eui=2220/
http://feeds.nytimes.com/click.phdo?i=b6a9c8fdd23c8a6658dd10ba57516d61
